Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1038/oncsis.2017.65 http://scihub22266oqcxt.onion/10.1038/oncsis.2017.65 C5608917!5608917!28805788     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Oncogenesis 2017 ; 6 (8): e371- Nephropedia Template TP {{tp|p=28805788|t=2017. Nrf2-Keap1 pathway promotes cell proliferation and diminishes ferroptosis |pdf=|usr=}}{{28805788}} gab.com Text Nrf2-Keap1 pathway promotes cell proliferation and diminishes ferroptosis JO: Oncogenesis http://www.kidney.de/pget.php?&tw=1&pmid=28805788 #FOAvip Cancer cells are hallmarked by high proliferation and imbalanced redox consumption and signaling. Various oncogenic pathways such as proliferation and evading cell death converge on redox-dependent signaling processes. Nrf2 is a key regulator in these redox-dependent events and operates in cytoprotection, drug metabolism and malignant progression in cancer cells. Here, we show that patients with primary malignant brain tumors (glioblastomas, WHO °IV gliomas, GBM) have a devastating outcome and overall reduced survival when Nrf2 levels are upregulated. Nrf2 overexpression or Keap1 knockdown in glioma cells accelerate proliferation and oncogenic transformation. Further, activation of the Nrf2-Keap1 signaling upregulates xCT (aka SLC7A11 or system Xc?) and amplifies glutamate secretion thereby impacting on the tumor microenvironment. Moreover, both fostered Nrf2 expression and conversely Keap1 inhibition promote resistance to ferroptosis. Altogether, the Nrf2-Keap1 pathway operates as a switch for malignancy in gliomas promoting cell proliferation and resistance to cell death processes such as ferroptosis. Our data demonstrate that the Nrf2-Keap1 pathway is critical for cancer cell growth and operates on xCT. Nrf2 presents the Achilles? heel of cancer cells and thus provides a valid therapeutic target for sensitizing cancer for chemotherapeutics. Twit Text FOAVip Nrf2-Keap1 pathway promotes cell proliferation and diminishes ferroptosis ????Oncogenesis http://www.kidney.de/pget.php?&tw=1&pmid=28805788 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28805788 #FOAvip English Wikipedia <ref>{{Cite pmid|28805788}}</ref> Nrf2-Keap1 pathway promotes cell proliferation and diminishes ferroptosis #MMPMID28805788 Fan Z; Wirth AK; Chen D; Wruck CJ; Rauh M; Buchfelder M; Savaskan N Oncogenesis 2017[Aug]; 6 (8): e371- PMID28805788show ga Cancer cells are hallmarked by high proliferation and imbalanced redox consumption and signaling. Various oncogenic pathways such as proliferation and evading cell death converge on redox-dependent signaling processes. Nrf2 is a key regulator in these redox-dependent events and operates in cytoprotection, drug metabolism and malignant progression in cancer cells. Here, we show that patients with primary malignant brain tumors (glioblastomas, WHO °IV gliomas, GBM) have a devastating outcome and overall reduced survival when Nrf2 levels are upregulated. Nrf2 overexpression or Keap1 knockdown in glioma cells accelerate proliferation and oncogenic transformation. Further, activation of the Nrf2-Keap1 signaling upregulates xCT (aka SLC7A11 or system Xc?) and amplifies glutamate secretion thereby impacting on the tumor microenvironment. Moreover, both fostered Nrf2 expression and conversely Keap1 inhibition promote resistance to ferroptosis. Altogether, the Nrf2-Keap1 pathway operates as a switch for malignancy in gliomas promoting cell proliferation and resistance to cell death processes such as ferroptosis. Our data demonstrate that the Nrf2-Keap1 pathway is critical for cancer cell growth and operates on xCT. Nrf2 presents the Achilles? heel of cancer cells and thus provides a valid therapeutic target for sensitizing cancer for chemotherapeutics. äNrf2-Keap1 pathway promotes cell proliferation and diminishes ferropto(epmc).pdf DeepDyve Pubget Overpricing